Catherine Han

Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer

Khine Nyein Myint, Riya Biswas, Yan Li et al. · Scientific Reports · 2019 · 262 citations · Full text

Medicine, Oncology, Pharmacology +14

Isocitrate dehydrogenase mutation as a therapeutic target in gliomas

Catherine Han, Tracy T. Batchelor · Chinese Clinical Oncology · 2017 · 41 citations · Full text

Medicine, Genetics, Oncology +17

Understanding Patient Preferences Regarding the Important Determinants of Breast Cancer Treatment: A Narrative Scoping Review

Hui Yee Yeo, Ai Ch’i Liew, Suz Jack Chan et al. · Patient Preference and Adherence · 2023 · 34 citations · Full text

Medicine, Oncology, Breast Oncology +13

Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients

Catherine Han, Prashannata Khwaounjoo, Dean H. Kilfoyle et al. · BMC Cancer · 2013 · 25 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Muir–Torre syndrome-associated pleomorphic liposarcoma arising in a previous radiation field

Masato Yozu, Pennie Symmans, Michael Dray et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2013 · 23 citations

Veterinary Medicine, Oncology, Radiation Oncology +10